Original Text: |
    Known intolerance to trastuzumab that persists after appropriate medical management. Patients who have a history of prior intolerance to trastuzumab that is controlled after medical management and who tolerate trastuzumab thereafter without reactions are eligible to participate
Disease/Condition: Breast cancer
Procedure: Trastuzumab
Drug: Trastuzumab
Biomarker: HER2 overexpression
Computable Rule: |
    "Known intolerance to trastuzumab that persists after appropriate medical management." AND ("Breast cancer" OR "HER2 overexpression") AND ("Trastuzumab")
